2013
A stylish, in-depth look at the renaissance in psychedelic drug research in light of current scientific, medical, and cultural knowledge.
85 min
CLEAR ALL
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.
1
Though researchers are still trying to understand the cognitive and therapeutic mechanics of psychedelics, they have concluded that psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy.
2
The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.
Drugs like LSD and MDMA are generating new interest among doctors for use in psychotherapy.
Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.
In this anthology edited by bestselling author Graham Hancock, 22 writers discuss psychedelics and their myriad connections to consciousness. Travel to South America, the American Southwest, outer space, inner space, and back in time to revisit Pahnke's The Good Friday experiment.